Understanding and identifying visual field progression

ABSTRACT

Detecting deterioration of visual field sensitivity measurements is important for the diagnosis and management of glaucoma. This review surveys the current methods for assessing progression that are implemented in clinical devices, which have been used in clinical trials, alongside more recent advances proposed in the literature. Advice is also offered to clinicians on what they can do to improve the collection of perimetric data to help analytical progression methods more accurately predict change. This advice includes a discussion of how frequently visual field testing should be undertaken, with a view towards future developments, such as digital healthcare outside the standard clinical setting and more personalised approaches to perimetry.

KEYWORDS:

• Gaucoma
• perimetry
• visual field metrics
• visual field progression

Disclosure statement

Authors AMM and AT have received research support from the following ophthalmic device manufacturers: Haag-Streit AG, Heidelberg Engineering GmBH, CREWT Medical Systems, CenterVue SpA, iCare OY.